drugset / Trial / NCT02647892

Optimal Lidocaine Buffering to Reduce Injection Pain in Local Anesthesia

NCT02647892

Phase 4 Terminated 70 enrolled University of Nebraska
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the optimal amount of lidocaine buffering needed to decrease injection pain when administering local anesthesia.

Timeline

Start
2016-01-08
Primary completion
2021-11-05
Completion
2021-11-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 5 mg/ml
Comparator Lidocaine Other / unclassified 7.5 mg/ml
Comparator Lidocaine Other / unclassified 9 mg/ml
Comparator Lidocaine Other / unclassified 10 mg/ml
Comparator sodium bicarbonate Diagnostic / imaging agent 10 %
Comparator sodium bicarbonate Diagnostic / imaging agent 25 %
Comparator sodium bicarbonate Diagnostic / imaging agent 50 %

Indications

No indication recorded.